Literature DB >> 10459157

Route of TT virus infection in children.

K Sugiyama1, K Goto, T Ando, F Mizutani, K Terabe, Y Kawabe, Y Wada.   

Abstract

TT virus (TTV) is a novel viral agent, detected recently in non-A to E hepatitis cases. Little is known about its natural history or routes of transmission in childhood. For the detection of serum TTV DNA, semi-nested polymerase chain reaction (PCR) was carried out using TTV-specific primers and TTV nucleotide sequences were determined by the dideoxy chain-mediated termination method. Five of the 70 children studied (including 20 hepatitis B virus [HBV] carriers, 40 children born to HBV carrier mothers and 10 children born to hepatitis C virus [HCV] carrier mothers) had serum TTV DNA. Three of the 5 children had siblings (4 in total), so that a total of 9 children were studied to determine the time of initial serum TTV DNA detection. In the 8 seropositive children, the time of serum TTV DNA detection ranged from 6 to 14 months after birth, and TTV DNA persisted thereafter throughout the follow-up period. The TTV DNA-negative child was assessed most recently at 6 months of age. TTV DNA was detected in only 2 of the 4 mothers tested (families 2 and 3). When 271-bp TTV DNA fragments from each of the 8 children were sequenced, the degree of homology between siblings in families 1-3 was 100%, 99.5%, and 92.3%, respectively. The degree of homology between child-mother pairs of families 2 and 3 was 99.5-100% and 62. 6-63.9%, respectively. The distribution of different TTV strains was consistent within families, except for family 3. None of the TTV-infected children had elevated levels of alanine aminotransferase or clinical signs of liver disease. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10459157     DOI: 10.1002/(sici)1096-9071(199910)59:2<204::aid-jmv13>3.0.co;2-t

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

1.  Molecular characterization of human Torque Teno virus.

Authors:  Youping Wei; Minyang Chen; Xia Yang; Liming Zhang; Lihua Rao; Feifang Yuan; Yangqin Wang; Jing Gong; Lianping Li
Journal:  Biomed Rep       Date:  2015-08-26

Review 2.  Molecular properties, biology, and clinical implications of TT virus, a recently identified widespread infectious agent of humans.

Authors:  M Bendinelli; M Pistello; F Maggi; C Fornai; G Freer; M L Vatteroni
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

3.  Fecal excretion of a novel human circovirus, TT virus, in healthy children.

Authors:  C L Lin; W Kyono; J Tongson; P K Chua; D Easa; R Yanagihara; V R Nerurkar
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

4.  In vivo and in vitro intragenomic rearrangement of TT viruses.

Authors:  Ludmila Leppik; Karin Gunst; Matti Lehtinen; Joakim Dillner; Karin Streker; Ethel-Michele de Villiers
Journal:  J Virol       Date:  2007-06-27       Impact factor: 5.103

5.  TT virus in the nasal secretions of children with acute respiratory diseases: relations to viremia and disease severity.

Authors:  Fabrizio Maggi; Massimo Pifferi; Claudia Fornai; Elisabetta Andreoli; Elena Tempestini; Marialinda Vatteroni; Silvano Presciuttini; Santino Marchi; Angelo Pietrobelli; Attilio Boner; Mauro Pistello; Mauro Bendinelli
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

6.  Association of torque teno virus (TTV) and torque teno mini virus (TTMV) with liver disease among patients coinfected with human immunodeficiency virus and hepatitis C virus.

Authors:  M García-Álvarez; J Berenguer; E Alvarez; M Guzmán-Fulgencio; J Cosín; P Miralles; P Catalán; J C López; J Ma Rodríguez; D Micheloud; Ma A Muñoz-Fernández; S Resino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09-16       Impact factor: 3.267

7.  Increased prevalence of anellovirus in pediatric patients with fever.

Authors:  Erin McElvania TeKippe; Kristine M Wylie; Elena Deych; Erica Sodergren; George Weinstock; Gregory A Storch
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.